article thumbnail

The European Commission’s New Compulsory Licensing Proposal: A Step Forward?

Bill of Health

To solve this tension, the Commission recognizes that patent law already offers a solution: compulsory licensing. The Proposal A compulsory license allows third parties to use a patent without asking prior permission from the owner of said patent. The powers to grant such a license will be in the hands of the Commission.

Licensing 285
article thumbnail

No Take-Backs: Moderna’s Attempt to Renege on its Vaccine Patent Pledge

Bill of Health

government funding, announced that it felt “a special obligation … to use our resources to bring this pandemic to an end as quickly as possible.” These pledges can take a variety of forms and have been made for decades in industries ranging from automotive (e.g., After the pandemic, it is willing to offer paid licenses.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Reasonable Pricing Clauses: A First Step Toward Ensuring Taxpayers a Fair Return on their Public R&D Investment

Bill of Health

Such a provision could prevent the public from paying twice for publicly-funded medical products—first through their taxes subsidizing government funded research and development, and second to procure the product in an inflated U.S. pharmaceutical market. Moreover, the NASDAQ Biotechnology Index increased by 374% from 1995 to 2000.

COVID-19 205
article thumbnail

Accenture Invests in QuantHealth to Accelerate Use of AI-Powered Clinical Trial Simulations to Drive Cost-Effective Drug Development

Healthcare IT Today

global lead of the Accenture Life Sciences business, said, “Through our investment in QuantHealth, we are further solidifying our commitment to utilizing advanced technologies to bring revolutionary change in the pharmaceutical industry. Petra Jantzer, Ph.D., Terms of the investment were not disclosed.

article thumbnail

How to Tackle Pharma’s 3 Biggest Compliance Risks Head-On with Verisys

Verisys

The onus of ensuring these CROs have proper controls in place often falls on the shoulders of the pharmaceutical company and can be challenging to monitor. Medication Samples Supplying medication samples to prescriber’s offices is common in the pharmaceutical industry, especially with launch brands.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2024

SQA

This standard is a globally recognized standard that provides guidelines for the governance and management of AI technologies. It provides a practical guide for the pharmaceutical industry on how to implement PACs within the framework of an effective Pharmaceutical Quality System (PQS) and in alignment with ICH quality guidelines.

FDA 52
article thumbnail

Health Provider News

Hall Render

Nevada, currently the wild west of birthing, is considering licensing midwifery NEW HAMPSHIRE Dartmouth Health opens new 5-story patient pavilion Report: Anthem has yet to process nearly $300 million in N.H. no longer calls for masks at all health care facilities to fight COVID-19, Gov.